A comprehensive approach to the central monitoring of clinical trials

por Bakobaki, Julie, Stenning, Sally, Joffe, Nicola, Meredith, Sarah
Publicado en Trials (2015)

Identifying additional studies for a systematic review of retention strategies in randomised controlled trials: making contact with trials units and trial methodologists

por Brueton, Valerie, Tierney, Jayne F., Stenning, Sally, Rait, Greta
Publicado en Syst Rev (2017)

Best practice guidance for the use of strategies to improve retention in randomized trials developed from two consensus workshops

por Brueton, Valerie, Stenning, Sally P., Stevenson, Fiona, Tierney, Jayne, Rait, Greta
Publicado en J Clin Epidemiol (2017)

Assessing the potential for prevention or earlier detection of on-site monitoring findings from randomised controlled trials: Further analyses of findings from the prospective TEMP...

por Cragg, William J, Hurley, Caroline, Yorke-Edwards, Victoria, Stenning, Sally P
Publicado en Clin Trials (2020)

Dynamic methods for ongoing assessment of site-level risk in risk-based monitoring of clinical trials: A scoping review

por Cragg, William J, Hurley, Caroline, Yorke-Edwards, Victoria, Stenning, Sally P
Publicado en Clin Trials (2021)

Strategies to reduce attrition in randomised trials

por Brueton, Valerie, Tierney, Jayne, Stenning, Sally, Nazareth, Irwin, Meredith, Sarah, Harding, Seeromanie, Rait, Greta
Publicado 2011

Update on the temper study: targeted monitoring, prospective evaluation and refinement

por Stenning, Sally, Joffe, Nicola, Batra, Priyanka, Jones, Catrin, Montana, Carlos Diaz, Tappenden, Nancy, Meredith, Sarah
Publicado 2013

Strategies to improve retention in randomised trials

por Brueton, Valerie C, Tierney, Jayne, Stenning, Sally, Harding, Seeromanie, Meredith, Sarah, Nazareth, Irwin, Rait, Greta
Publicado en Cochrane Database Syst Rev (2013)

Implementing monitoring triggers and matching of triggered and control sites in the TEMPER study: a description and evaluation of a triggered monitoring management system

por Diaz-Montana, Carlos, Cragg, William J., Choudhury, Rahela, Joffe, Nicola, Sydes, Matthew R., Stenning, Sally P.
Publicado en Trials (2019)

Long-term outcomes with intensive induction chemotherapy (carboplatin, bleomycin, vincristine and cisplatin/bleomycin, etoposide and cisplatin) and standard bleomycin, etoposide an...

por Cafferty, Fay H., White, Jeff D., Shamash, Jonathan, Hennig, Ivo, Stenning, Sally P., Huddart, Robert A.
Publicado en Eur J Cancer (2020)

Triggered or routine site monitoring visits for randomised controlled trials: results of TEMPER, a prospective, matched-pair study

por Stenning, Sally P, Cragg, William J, Joffe, Nicola, Diaz-Montana, Carlos, Choudhury, Rahela, Sydes, Matthew R, Meredith, Sarah
Publicado en Clin Trials (2018)

Prognostic and predictive markers in recurrent high grade glioma; results from the BR12 randomised trial

por Collins, Vincent Peter, Ichimura, Koichi, Di, Ying, Pearson, Danita, Chan, Ray, Thompson, Lindsay C, Gabe, Rhian, Brada, Michael, Stenning, Sally P
Publicado en Acta Neuropathol Commun (2014)

A Randomised Phase 2 Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP in Poor-prognosis Germ Cell Tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604)

por Huddart, Robert A., Gabe, Rhian, Cafferty, Fay H., Pollock, Philip, White, Jeff D., Shamash, Jonathan, Cullen, Michael H., Stenning, Sally P.
Publicado en Eur Urol (2015)

Defining a New Prognostic index for Stage I Non-seminomatous Germ Cell Tumors using CXCL12 Expression and Proportion of Embryonal Carcinoma

por Gilbert, Duncan C, Al-Saadi, Reem, Thway, Khin, Chandler, Ian, Berney, Daniel, Gabe, Rhian, Stenning, Sally P, Sweet, Joan, Huddart, Robert, Shipley, Janet M
Publicado en Clin Cancer Res (2015)

A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY1...

por Mead, Graham M., Barrans, Sharon L., Qian, Wendi, Walewski, Jan, Radford, John A., Wolf, Max, Clawson, Simon M., Stenning, Sally P., Yule, Claire L., Jack, Andrew S.
Publicado 2008

Pharmacogenetic analysis of the UKMRC (Medical Research Council) MAGIC trial: association of polymorphisms with toxicity and survival in patients treated with perioperative epirubi...

por Smyth, Elizabeth, Zhang, Shenli, Cunningham, David, Wotherspoon, Andrew, Soong, Richie, Peckitt, Clare, Valeri, Nicola, Fassan, Matteo, Rugge, Massimo, Okines, Alicia, Allum, William, Stenning, Sally, Nankivell, Matthew, Langley, Ruth, Tan, Patrick
Publicado en Clin Cancer Res (2017)

Mismatch Repair Deficiency, Microsatellite Instability, and Survival: An Exploratory Analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) Trial

por Smyth, Elizabeth C., Wotherspoon, Andrew, Peckitt, Clare, Gonzalez, David, Hulkki-Wilson, Sanna, Eltahir, Zakaria, Fassan, Matteo, Rugge, Massimo, Valeri, Nicola, Okines, Alicia, Hewish, Madeleine, Allum, William, Stenning, Sally, Nankivell, Matthew, Langley, Ruth, Cunningham, David
Publicado en JAMA Oncol (2017)

Reduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma

por Obulkasim, Askar, Ylstra, Bauke, van Essen, Hendrik F., Benner, Christian, Stenning, Sally, Langley, Ruth, Allum, William, Cunningham, David, Inam, Imran, Hewitt, Lindsay C., West, Nicolas P., Meijer, Gerrit A., van de Wiel, Mark A., Grabsch, Heike I.
Publicado en Oncotarget (2016)

Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label...

por Alderson, Derek, Cunningham, David, Nankivell, Matthew, Blazeby, Jane M, Griffin, S Michael, Crellin, Adrian, Grabsch, Heike I, Langer, Rupert, Pritchard, Susan, Okines, Alicia, Krysztopik, Richard, Coxon, Fareeda, Thompson, Joyce, Falk, Stephen, Robb, Clare, Stenning, Sally, Langley, Ruth E
Publicado en Lancet Oncol (2017)

Biopsy proportion of tumour predicts pathological tumour response and benefit from chemotherapy in resectable oesophageal carcinoma: results from the UK MRC OE02 trial

por Hale, Matthew D., Nankivell, Matthew, Hutchins, Gordon G., Stenning, Sally P., Langley, Ruth E., Mueller, Wolfram, West, Nicholas P., Wright, Alexander I., Treanor, Darren, Hewitt, Lindsay C., Allum, William H., Cunningham, David, Hayden, Jeremy D., Grabsch, Heike I.
Publicado en Oncotarget (2016)